1 recruiting, 1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Olivopontocerebellar Atrophy V: new trials by email Literature Review of Olivopontocerebellar Atrophy V trials Research Report on Olivopontocerebellar Atrophy V
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of CAD-1883 for Spinocerebellar Ataxia CAD-1883, Placebos - Spinocerebellar Ataxias, Spinocerebellar Ataxia Type 1 | Phase 2 | Withdrawn | Cadent Therapeutics | 2021-06-01 | 2021-04-08 | |
| Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford Rare Disorders, Undiagnosed Disorders | Recruiting | Sanford Health | 20000 | 2010-07-01 | 2026-10-28 |
Ataxia (2) · Machado-Joseph Disease (2) · Spinocerebellar Ataxia 10 (2) · Spinocerebellar Ataxias (2) · Spinocerebellar ataxia 8 (2) · 3-Methylglutaconic Aciduria, Type V (1) · Achalasia Addisonianism Alacrimia syndrome (1) · Acrodysostosis (1) · Activated PI3K-delta Syndrome (1) · Addison Disease (1) · Alagille Syndrome (1) · Alstrom Syndrome (1) · Amnesia, Transient Global (1) · Aniridia (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Cerebellar Ataxia (2) · Cerebellar Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Dyskinesias (2) · Genetic Diseases, Inborn (2) · Heredodegenerative Disorders, Nervous System (2) · Nervous System Diseases (2) · Neurodegenerative Diseases (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Spinal Cord Diseases (2) · Abnormalities, Multiple (1)
Cadent Therapeutics (1) · Sanford Health (1)
United States (2)